89bio, Inc. (ETNB) Misses Q2 EPS by 21c
89bio, Inc. (NASDAQ: ETNB) reported Q2 EPS of ($0.71), $0.21 worse than the analyst estimate of ($0.50).
For earnings history and earnings-related data on 89bio, Inc. (ETNB) click here.
89bio, Inc. (NASDAQ: ETNB) reported Q2 EPS of ($0.71), $0.21 worse than the analyst estimate of ($0.50).
For earnings history and earnings-related data on 89bio, Inc. (ETNB) click here.